Renaissance Capital logo

Vincerx Pharma (LifeSci Acquisition) Priced, Nasdaq: VINC

Blank check company formed by LifeSci Capital targeting the healthcare industry (completed 12/23/2020).

Industry: SPAC

First Day Return: +2.5%

Industry: SPAC

We are a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. Although there is no restriction or limitation on what industry our target operates in, it is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development. At the time of preparing this prospectus, we have not identified any specific business combination, nor has anyone on our behalf initiated or engaged in any substantive discussions, formal or otherwise, related to such a transaction.
more less
IPO Data
IPO File Date 02/14/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 6.0
Deal Size ($mm) $60
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 03/05/2020
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $60
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters New York, NY, United States
Founded 2018
Employees at IPO 2
Website www.lifescicapital.com

Vincerx Pharma (LifeSci Acquisition) (VINC) Performance